Erratum: The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (American Journal of Gastroenterology DOI: 10.1038/ajg.2009.321);The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt

American Journal of Gastroenterology

Volumn 104, Issue 10, 2009, Pages 2458-2466

  Rabie, Rania Nancy ^a   Cazzaniga, Massimo ^b   Salerno, Francesco ^b   Wong, Florence ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; ARTICLE; ASCITES; CAUSE OF DEATH; CLEARANCE; CLINICAL ASSESSMENT; CLINICAL INDICATOR; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART FUNCTION; HEMODYNAMIC PARAMETERS; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PORTAL VEIN BLOOD PRESSURE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROBABILITY; SCORING SYSTEM; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; ECHOGRAPHY; HEART FUNCTION TEST; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HOSPITALIZATION; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION TESTS; HEMODYNAMICS; HUMANS; KIDNEY FUNCTION TESTS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 70349693457     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.436     Document Type: Erratum

References (42)

1. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41:386-400
2. Braverman AC, Steiner MA, Picus D et al. High-output congestive heart failure following transjugular intrahepatic portal-systemic shunting. Chest 1995; 107:1467-1469
3. Naritaka Y, Ogawa K, Shimakawa T et al. Clinical experience of transjugular intrahepatic portosystemic shunt (TIPS) and its Effects on systemic hemodynamics. Hepatogastroenterology 2004; 51:1470-1472
4. Pozzi M, Ratti L, Redaelli E et al. Cardiovascular abnormalities in special conditions of advanced cirrhosis. The circulatory adaptive changes to specific therapeutic procedures for the management of refractory ascites. Gastroenterol Hepatol 2006; 29:263-272
5. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24:451-459
6. Moller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002; 87:9-15
7. Wong F, Girgrah N, Graba J et al. The Effect of cirrhotic cardiomyopathy on the cardiac response to exercise in cirrhosis. Gut 2001; 49:268-275
8. Wong F, Liu P, Lilly L et al. The role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci 1999; 97:259-267
9. Pozzi M, Carugo S, Boari G et al. Functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26:1131-1137
10. Finucci G, Desideri A, Sacerdoti D et al. Left ventricular diastolic dysfunction in liver cirrhosis. Scand J Gastroenterol 1996; 31:279-284
11. Valeriano V, Funaro S, Lionetti R et al. Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol 2000; 95:3200-3205
12. Bernardi M, Rubboli A, Trevisani F et al. Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis. J Hepatol 1991; 12:207-216
13. LaffiG, Barletta G, La Villa G et al. Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. Gastroenterology 1997; 113:891-898
14. Grose RD, Nolan J, Dillon JF et al. Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol 1995; 22:326-332
15. Zambruni A, Trevisani F, Caraceni P et al. Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol 2006; 44:994-1002
16. Follo A, Llovet JM, Navasa M et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994; 20:1495-1501
17. Terra C, Guevara M, Torre A et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 2005; 129:1944-1953
18. Cazzaniga M, Salerno F, Pagnozzi G et al. Diastolic dysfunction is associated with poor survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Gut 2007; 56:869-875
19. Otto CM, Pearlman AS. Echocardiographic evaluation of left and right systolic and diastolic function. In Otto CM, Pearlman AS (eds). Textbook of Clinical Echocardiography. WB Saunders: Philadelphia, PA, 1995, pp 85-136
20. Moore KP, Wong F, Gines P et al. The management of ascites-Report on the Consensus Conference of the International Ascites Club. Hepatology 2003; 38:258-266
21. Henry WL, DeMaria A, Gramiak R et al. Report of the American Society of Echocardiography: nomenclature and standards in two-dimensional echocardiography. Circulation 1980; 62:212-217
22. Bruch C, Schmermund A, Bartel T et al. Tissue Doppler imaging: a new technique for assessment of pseudonormalization of the mitral inflow pattern. Echocardiography 2000; 17:539-546
23. Bryg RJ, Williams GA, Labovitz AJ. Effect of aging on left ventricular diastolic filling in normal subjects. Am J Cardiol 1987; 59:971-974
24. Mantero A, Gentile F, Azzollini M et al. Effect of sample volume location on Doppler-derived transmitral inflow velocity values in 288 normal subjects 20 to 80 years old: an echocardiographic, two-dimensional color Doppler cooperative study. J Am Soc Echocardiogr 1998; 3:280-288
25. Mantero A, Gentile F, Gualtierotti C et al. Left ventricular diastolic parameters in 288 normal subjects from 20 to 80 years old. Eur Heart J 1995; 16:94-105
26. Shutov AM, Kondratyeva NI, Kulikova ES. Does E/A ratio correctly estimate diastolic dysfunction in patients with chronic renal failure? Nephrol Dial Transplant 2000; 15:1256-7
27. Bahl VK, Malhotra OP, Kumar D et al. Noninvasive assessment of systolic and diastolic left ventricular function in patients with chronic severe anaemia: a combined M-mode, two-dimensional, and Doppler echocardiographic study. Am Heart J 1992; 124:1516-1523
28. Josephs W, Odenthal HJ, Lenga P et al. Doppler echocardiography description of diastolic function disorders in terminal renal failure-new characterization of uremic cardiomyopathy. Z Kardiol 1990; 79:482-488
29. Galderisi M, Benjamin EJ, Evans JC et al. Impact of heart rate and PR interval on Doppler indexes of left ventricular diastolic filling in an elderly cohort (the Framingham Heart Study). Am J Cardiol 1993; 72:1183-1187 (Pubitemid 24050059)
30. Lunseth JH, Olmstead EG, Abboud F. A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. Arch Intern Med 1958; 102:405-413
31. Piscaglia F, Serra C, Celli N et al. Cardiac abnormalities in cirrhosis. Am J Gastroenterol 2001; 96:2503-2505
32. La Villa G, Barletta G, Romanelli RG et al. Cardiovascular Effects of canrenone in patients with preascitic cirrhosis. Hepatology 2002; 35:1441-1448
33. De BK, Majumdar D, Das D et al. Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis. J Hepatol 2003; 39:315-319
34. Ruiz del Arbol L, Monescillo A, Arocena C et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 2005; 42:439-447
35. Wong F, Sniderman K, Liu P et al. The Effects of transjugular intrahepatic portasystemic shunt on systemic and renal hemodynamics and sodium homeostasis in cirrhotic patients with refractory ascites. Ann Intern Med 1995; 122:816-822
36. Huonker M, Schumacher YO, Ochs A et al. Cardiac function and haemodynamics in alcoholic cirrhosis and Effects of the transjugular intrahepatic portosystemic stent shunt. Gut 1999; 44:743-748
37. Azoulay D, Castaing D, Dennison A et al. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 1994; 19:129-132
38. Malinchoc M, Kamath PS, Gordon FD et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871
39. Salerno F, Merli M, Cazzaniga M et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002; 36:494-500
40. Torregrosa M, Aguade S, Dos L et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol 2005; 42:68-74
41. Wong F, Blendis L. The pathophysiologic basis for the treatment of cirrhotic ascites. Clin Liver Dis 2001; 5:819-832
42. D'Amico G, Luca A, Morabito A et al. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology 2005; 129:1282-93.